https://www.selleckchem.com/pr....oducts/crenolanib-cp
8 vs 1.4±0.9 vs1.2±0.6, p0.001] and improvement in HOMA-Insulin sensitivity [34±17 vs 93±50 vs 112±62, p0.001] from baseline to 6 and 12 months post-surgery respectively. There was a significant (p0.001) reduction in the usage of anti-diabetes medications post-surgery. The limitations of this study are small sample size and limited follow up period of 1 year. Among T2DM patients, metabolic surgery resulted in significant improvement in beta cell function and insulin sensitivity along with reduction in anti-diabe
Like
Comment
Share
